Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants
Authors
Keywords
-
Journal
Cardiovascular Diabetology
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-14
DOI
10.1186/s12933-020-01043-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The comparison of non-vitamin K antagonist oral anticoagulants versus well-managed warfarin with a lower INR target of 1.5 to 2.5 in Asians patients with non-valvular atrial fibrillation
- (2019) Yi-Hsin Chan et al. PLoS One
- Concerns about clinical efficacy and safety of warfarin in diabetic patients with atrial fibrillation
- (2019) Sho-ichi Yamagishi Cardiovascular Diabetology
- Effectiveness and Safety of Rivaroxaban and Warfarin for Prevention of Major Adverse Cardiovascular or Limb Events in Nonvalvular Atrial Fibrillation Patients with Type 2 Diabetes
- (2019) William L. Baker et al. DIABETES OBESITY & METABOLISM
- Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage
- (2019) Peter Brønnum Nielsen et al. STROKE
- Comparison of the New Oral Anticoagulants and Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Systematic Review and Meta-Analysis
- (2019) Yasmin de Souza Lima Bitar et al. Drugs in research & development
- Atrial fibrillation and its arrhythmogenesis associated with insulin resistance
- (2019) Yi-Hsin Chan et al. Cardiovascular Diabetology
- The impact of body weight and diabetes on new-onset atrial fibrillation: a nationwide population based study
- (2019) Yun Gi Kim et al. Cardiovascular Diabetology
- Non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation patients with concomitant peripheral artery disease
- (2019) Hsin-Fu Lee et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Use of non-vitamin K oral anticoagulants in people with atrial fibrillation and diabetes mellitus
- (2018) O. Itzhaki Ben Zadok et al. DIABETIC MEDICINE
- The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
- (2018) Jan Steffel et al. EUROPEAN HEART JOURNAL
- Association of arterial calcification with chronic limb ischemia in patients with peripheral artery disease
- (2018) Sara L. Zettervall et al. JOURNAL OF VASCULAR SURGERY
- Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
- (2018) Sonia S Anand et al. LANCET
- Antithrombotic Therapy for Atrial Fibrillation
- (2018) Gregory Y.H. Lip et al. CHEST
- Pathology of Peripheral Artery Disease in Critical Limb Ischemia
- (2018) Navneet Narula et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
- (2018) Jason G. Andrade et al. CANADIAN JOURNAL OF CARDIOLOGY
- 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
- (2017) Victor Aboyans et al. EUROPEAN HEART JOURNAL
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
- (2017) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Warfarin Use Is Associated With Progressive Coronary Arterial Calcification
- (2017) Jordan Andrews et al. JACC-Cardiovascular Imaging
- Atrial Fibrillation, Type 2 Diabetes, and Non–Vitamin K Antagonist Oral Anticoagulants
- (2017) Anna Plitt et al. JAMA Cardiology
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry
- (2016) Seil Oh et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Increased Peripheral Arterial Calcification in Patients Receiving Warfarin
- (2016) Kum Hyun Han et al. Journal of the American Heart Association
- Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial)
- (2015) Sameer Bansilal et al. AMERICAN HEART JOURNAL
- Glycated hemoglobin and risk of first episode stroke in diabetic patients with atrial fibrillation: A cohort study
- (2015) W. Saliba et al. HEART RHYTHM
- Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial
- (2015) Michela Brambatti et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation
- (2015) Kang-Ling Wang et al. STROKE
- Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775 385 individuals and 12 539 strokes
- (2014) Sanne A E Peters et al. LANCET
- A tutorial on propensity score estimation for multiple treatments using generalized boosted models
- (2013) Daniel F. McCaffrey et al. STATISTICS IN MEDICINE
- Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study
- (2012) Leif Friberg et al. EUROPEAN HEART JOURNAL
- Matrix Gla Protein Metabolism in Vascular Smooth Muscle and Role in Uremic Vascular Calcification
- (2011) Koba A. Lomashvili et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA2DS2-VASc risk stratification scores
- (2010) B. Pamukcu et al. AGE AND AGEING
- A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
- (2010) Ron Pisters et al. CHEST
- Bleeding Increases the Risk of Ischemic Events in Patients With Peripheral Arterial Disease
- (2009) Eline S. van Hattum et al. CIRCULATION
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
- (2009) Peter C. Austin STATISTICS IN MEDICINE
- Use of Stabilized Inverse Propensity Scores as Weights to Directly Estimate Relative Risk and Its Confidence Intervals
- (2009) Stanley Xu et al. VALUE IN HEALTH
- Tibial Artery Calcification as a Marker of Amputation Risk in Patients With Peripheral Arterial Disease
- (2008) Raul J. Guzman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search